Clinical Trial Update: Research Into the Treatment of Anemia for Critically Ill Patients Admitted to Intensive Care Units (ICU) [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating a treatment for anemia in critically ill ICU patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Anemia | Phase 3 | Status: COMPLETED